ABSTRACT
Gram-negative bacteria have an outer membrane (OM) impermeable to many toxic compounds that can be further strengthened during stress. In Enterobacteriaceae, the envelope contains enterobacterial common antigen (ECA), a carbohydrate-derived moiety conserved throughout Enterobacteriaceae, the function of which is poorly understood. Previously, we identified several genes in Escherichia coli K-12 responsible for an RpoS-dependent decrease in envelope permeability during carbon-limited stationary phase. For one of these, yhdP, a gene of unknown function, deletion causes high levels of both vancomycin and detergent sensitivity, independent of growth phase. We isolated spontaneous suppressor mutants of yhdP with loss-of-function mutations in the ECA biosynthesis operon. ECA biosynthesis gene deletions suppressed envelope permeability from yhdP deletion independently of envelope stress responses and interactions with other biosynthesis pathways, demonstrating suppression is caused directly by removing ECA. Furthermore, yhdP deletion changed cellular ECA levels and yhdP was found to co-occur phylogenetically with the ECA biosynthesis operon. Cells make three forms of ECA: ECA lipopolysaccharide (LPS), an ECA chain linked to LPS core; ECA phosphatidylglycerol, a surface-exposed ECA chain linked to phosphatidylglycerol; and cyclic ECA, a cyclized soluble ECA molecule found in the periplasm. We determined that the suppression of envelope permeability with yhdP deletion is caused specifically by the loss of cyclic ECA, despite lowered levels of this molecule found with yhdP deletion. Furthermore, removing cyclic ECA from wild-type cells also caused changes to OM permeability. Our data demonstrate cyclic ECA acts to maintain the OM permeability barrier in a manner controlled by YhdP.
KEYWORDS: ECA, Enterobacteriaceae, Escherichia coli, YhdP, enterobacterial common antigen, outer membrane
IMPORTANCE
Enterobacterial common antigen (ECA) is a surface antigen made by all members of Enterobacteriaceae, including many clinically relevant genera (e.g., Escherichia, Klebsiella, Yersinia). Although this surface-exposed molecule is conserved throughout Enterobacteriaceae, very few functions have been ascribed to it. Here, we have determined that the periplasmic form of ECA, cyclic ECA, plays a role in maintaining the outer membrane permeability barrier. This activity is controlled by a protein of unknown function, YhdP, and deletion of yhdP damages the OM permeability barrier in a cyclic ECA-dependent manner, allowing harmful molecules such as antibiotics into the cell. This role in maintenance of the envelope permeability barrier is the first time a phenotype has been described for cyclic ECA. As the Gram-negative envelope is generally impermeable to antibiotics, understanding the mechanisms through which the barrier is maintained and antibiotics are excluded may lead to improved antibiotic delivery.
INTRODUCTION
The cellular envelope of Gram-negative bacteria consists of an inner membrane (IM) surrounding the cytoplasm, an asymmetrical outer membrane (OM), and a thin layer of peptidoglycan found in the periplasm separating the two membranes (1). While the inner leaflet of the OM is composed of phospholipids, the outer leaflet is mainly composed of lipopolysaccharide (LPS). LPS possesses a number of negatively charged residues that are bridged by divalent cations to form a strong network of interactions between neighboring LPS molecules (2). Due to these interactions and the amphiphilic nature of LPS, the OM provides the cell a robust permeability barrier, resistant to both large and hydrophobic molecules (3). For this reason, the OM has proven an impediment for the design of new antibiotics to treat Gram-negative bacterial infections.
Enterobacterial common antigen (ECA) is an invariant carbohydrate-derived molecule that is present in the OM and periplasm of members of Enterobacteriaceae (4). Although ECA is restricted to one family of bacteria, four of the seven species identified by the World Health Organization as being of high concern due to frequent antibiotic-resistant infections are members of this family (Klebsiella pneumoniae, Escherichia coli, nontyphoidal Salmonella, and Shigella species) (5). Despite the conserved nature of this molecule within Enterobacteriaceae (6), its function is largely unknown. In part, this is because the biosynthesis pathways for ECA, O antigen, and peptidoglycan overlap in such a way that gene deletions preventing ECA biosynthesis often also prevent O-antigen production (7–9) or perturb peptidoglycan biosynthesis, causing envelope stress responses to be activated (i.e., Cpx, Rcs, σE) (10–12). Thus, in interpreting the results of high-throughput screens (13–16), it is difficult to determine whether phenotypes are directly related to the presence or absence of ECA or are instead related to changes to other aspects of the cell envelope. Nevertheless, it is thought that ECA plays a small role in bile salt resistance and in organic acid resistance (17, 18). It is generally assumed that the surface-exposed forms of ECA are responsible for these phenotypes. In addition, in Salmonella enterica serovar Typhimurium, O-antigen and ECA biosynthesis are not genetically connected, and the first gene in ECA biosynthesis, wecA, can be deleted without activating stress responses, affecting O-antigen biosynthesis, or impairing peptidoglycan biosynthesis (19). Studies in this strain have demonstrated that cells without ECA are deficient in pathogenesis (19), suggesting that ECA plays an important role in the host.
The structure of ECA is conserved throughout Enterobacteriaceae, with each unit of ECA consisting of GlcNAc (N-acetylglucosamine), ManNAcA (N-acetyl-D-mannosaminuronic acid), and Fuc4NAc (4-acetamido-4,6-dideoxy-d-galactose) (20, 21). The pathway of ECA biosynthesis is analogous to that of O-antigen biosynthesis (see Fig. S1 in the supplemental material). GlcNAc-1-phosphate is linked to undecaprenyl-phosphate (Und-P), a lipid carrier in the IM also used for the biosynthesis of O antigen, peptidoglycan, and capsule carbohydrates, and then ManNAcA and Fuc4NAc are attached (22, 23). Many genes in the ECA biosynthesis operon are responsible for synthesizing these sugars and linking them to Und-P (22, 24, 25). The ECA unit linked to Und-P is then flipped across the IM by WzxE (26). The ECA chains are polymerized by WzyE (27), and the chain length is controlled by WzzE (28). Three forms of ECA are made from polymerized ECA chains. In the first, LPS-linked ECA (ECALPS), the ECA chain is transferred to the core sugar moiety of LPS by WaaL (29), the same gene responsible for attaching O antigen to core, and the molecule is transferred to the cell surface, presumably by the Lpt system. In the second, phosphatidylglycerol-linked ECA (ECAPG), the ECA chain is attached to phosphoglyceride by a phosphodiester linkage (30) and the molecule is surface exposed through an unknown pathway (31, 32). In the third form, cyclic ECA (ECACYC), an ECA chain of a precise chain length (4 to 6, depending on species) is cyclized in a reaction dependent on WzzE (33–35). This molecule remains in the periplasm (34).
Previously, we investigated changes to the Escherichia coli K-12 OM that occur during growth under different nutrient conditions (36) and determined that an RpoS-dependent mechanism strengthens the envelope permeability barrier under carbon-limiting conditions in a manner that depends on the presence of the genes for several proteins. Of these, YhdP is a large protein of unknown function that is predicted to be located in the IM with the majority of the protein exposed to the periplasm (37). Unlike our other hits, yhdP deletion (ΔyhdP) has strong phenotypes regardless of growth phase. In fact, in a large-scale study on the effects of gene deletions on chemical sensitivity (38), yhdP scored second highest for SDS EDTA (sodium dodecyl sulfate, ethylenediaminetetraacetic acid) sensitivity as well as in the top 15 hits for vancomycin sensitivity. Despite the high level of envelope permeability caused with deletion of yhdP, the function of YhdP is completely unknown. In addition, yhdP appears to be restricted phylogenetically (39), suggesting that it may play a role that is specific to a subset of species.
Here, we demonstrate that mutations that block ECA biosynthesis restore the envelope permeability barrier of ΔyhdP strains. Furthermore, we demonstrate that yhdP, which phylogenetically co-occurs with ECA biosynthesis genes, directly or indirectly controls ECA levels. We were able to trace the suppression specifically to the removal of ECACYC and demonstrate that, even in a wild-type background, removing ECACYC changes the OM permeability barrier. Therefore, ECACYC plays a role in maintaining the OM permeability barrier, and its activity is regulated by YhdP.
RESULTS
Deletion of yhdP causes OM permeability.
Our initial screen identifying yhdP was based on sensitivity to SDS treatment during stationary phase, and we also found that ΔyhdP caused sensitivity to 2% SDS in actively growing cells (36); therefore, we treated yhdP+ and ΔyhdP cells with SDS and increasing concentrations of EDTA and measured their growth. EDTA disrupts the bridging of LPS molecules by divalent cations, sensitizing the OM to the presence of detergents and allowing for the detection OM defects (40). Both yhdP+ and ΔyhdP cells grew to stationary phase with 0.05% SDS alone; however, a low concentration of EDTA (0.25 mM) caused a large growth defect in ΔyhdP cells, while causing a minimal effect on yhdP+ cells (Fig. 1A). In addition, a higher concentration of EDTA (0.5 mM) completely impaired the growth of ΔyhdP cells, while still allowing for growth of yhdP+ cells. These data suggest that there is a change in outer membrane structure when YhdP is removed, and so we investigated whether ΔyhdP causes permeability to other toxic agents.
Disk assay results suggested that ΔyhdP cells might be sensitive to vancomycin. Vancomycin is a glycopeptide antibiotic that targets peptidoglycan biosynthesis, which is commonly used to treat antibiotic-resistant Gram-positive infections but is largely incapable of traversing the Gram-negative OM (41). Permeability of the OM to vancomycin is thought to be caused by “cracks” between patches of phospholipids and LPS (42). We analyzed growth curves of yhdP+ and ΔyhdP cells with increasing dosages of vancomycin. Similarly to ΔyhdP’s SDS EDTA sensitivity, a low dose of vancomycin (50 µg/ml) caused lysis of ΔyhdP cells while not affecting yhdP+ growth (Fig. 1B). A higher dose of vancomycin (100 µg/ml) completely inhibited growth of ΔyhdP cells while only minimally affecting yhdP+ cells. In fact, the increase in vancomycin sensitivity with ΔyhdP can also be observed by a lowering of the vancomycin MIC (MIC) for this strain (Fig. S2). Both the increased vancomycin and SDS EDTA sensitivity of ΔyhdP cells suggest that there is a change in OM structure in this mutant that leads to increased permeability.
Disrupting ECA biosynthesis suppresses envelope permeability in ΔyhdP strains.
As no functions are known for YhdP, we then sought to isolate mutations suppressing strain ΔyhdP’s envelope permeability defects in order to determine in what pathway YhdP might be working. The slight growth we observed late after SDS EDTA and vancomycin treatment (Fig. 1) suggested that spontaneous suppressor mutants are common within ΔyhdP strain cultures. Therefore, we plated ΔyhdP cells on a concentration of vancomycin at which growth of these cells is inhibited but yhdP+ cells could grow, and we isolated spontaneous suppressor mutants that were capable of growth on this medium. Then, we conducted a secondary screen of these suppressors to identify those that restored both vancomycin and SDS EDTA resistance. We isolated seven spontaneous suppressors that restored both phenotypes, all of which mapped to the ECA biosynthesis (wec) operon. All seven appeared to be loss-of-function alleles (Fig. 2A and B).
We then asked whether suppression of the ΔyhdP strain envelope permeability by disruption of the wec operon is specific to yhdP or is a general mechanism of vancomycin and SDS EDTA resistance. To answer this question, we utilized a deletion allele of bamE, a component of the β-barrel assembly machine responsible for folding outer membrane proteins (OMPs) into the outer membrane (43). Removal of this nonessential lipoprotein from the complex leads to a similar level of vancomycin sensitivity as ΔyhdP and causes slight SDS EDTA sensitivity (44, 45). We combined this deletion with a deletion of wecA, which is responsible for the addition of the first sugar in ECA to Und-P (46). Some vancomycin resistance was caused by deletion of wecA alone (Fig. 2C). When combined with a deletion of bamE, wecA deletion caused only minimal suppression of vancomycin sensitivity and worsened the bamE SDS EDTA sensitivity. In contrast, wecA deletion fully suppressed both the vancomycin and SDS EDTA sensitivities of a ΔyhdP strain. These data demonstrate that disruption of ECA biosynthesis is not a universal suppressor of vancomycin and SDS EDTA sensitivity and suggest that this suppression is specific to the ΔyhdP strain.
We conducted a transposon mutagenesis screen in an effort to identify additional suppressors of the ΔyhdP mutant strain envelope permeability. Briefly, we identified vancomycin-resistant clones from a pool of 10,000 transposon mutants in a ΔyhdP strain, mapped the transposon insertion sites in these mutants, and conducted a secondary screen for SDS EDTA resistance (Fig. S3A). The only mutations we identified that suppressed both the vancomycin and SDS EDTA phenotypes were in the wec operon (Table S1); furthermore, we identified mutations in every gene in the wec operon except those that are redundant with O-antigen biosynthesis genes (rffG, wzxE) (34, 47) and wzyE, for which disruption is toxic (34) (Fig. S3B). Given that the wec genes form an operon, it is likely that some of these insertions may be polar. With more than 2× genome coverage, wec operon mutations were the only mutations to suppress both of ΔyhdP’s phenotypes, suggesting that our suppressor screen may be saturated.
Loss of ECA is directly responsible for the suppression of the ΔyhdP strain.
Because the ECA biosynthetic pathway interacts with the biosynthesis pathway for peptidoglycan and other extracytoplasmic glycans, disruption of ECA biosynthesis can cause cellular changes that are more wide-ranging than simple removal of ECA. Specifically, O-antigen biosynthesis, peptidoglycan biosynthesis, and ECA biosynthesis all compete for both precursor sugar molecules and for the lipid carrier on which the molecules are assembled, Und-P. Although our strains are O-antigen negative, when intermediate steps in the ECA biosynthesis pathway are disrupted, ECA intermediates (aminoglycans linked to Und-P-P) accumulate and sequester Und-P, stressing the peptidoglycan biosynthesis pathway (10). In contrast, when the first step in ECA biosynthesis (catalyzed by WecA) (46) is prevented, the pool of sugar precursors and Und-P available for peptidoglycan synthesis is increased. Therefore, we sought to determine whether (i) the phenotypes of ΔyhdP mutant cells were caused by Und-P stress and (ii) whether relieving Und-P stress suppresses the ΔyhdP strain.
Stress on the pool of Und-P has previously been detected using linkage disruption with a marker linked to mrcB::kan (48). As mrcB (PBP1B) is important for transglycosylation and transpeptidation of peptidoglycan precursors (49), deletion of mrcB in a strain with stress on the pool of available Und-P causes significant toxicity and can be synthetically lethal. This causes disruption of the linkage between the Tn10 marker and the mrcB deletion (i.e., fewer colonies with the Tn10 marker have received the mrcB deletion). However, we detected no linkage disruption with the ΔyhdP strain in the presence or absence of wecA (Fig. S4A), suggesting that the ΔyhdP mutant does not cause lipid carrier stress. To relieve possible Und-P stress, we overexpressed uppS, responsible for synthesizing Und-P, and murA, responsible for the first committed step in peptidoglycan synthesis (50, 51). Overexpression of these genes has previously been shown to relieve peptidoglycan stress caused by Und-P availability (48, 52). Overexpression of these genes had no effect on envelope permeability in a ΔyhdP background (Fig. 3A). Overexpression of uppP, a gene responsible for recycling Und-P (53), and mrcB, the gene encoding PBP1B, also had no effect on the ΔyhdP strain's envelope permeability (Fig. S4B). These data show that the phenotypes of the ΔyhdP deletion mutant are not caused by Und-P stress.
To verify further that the mechanism of ΔyhdP strain suppression by disruption of the ECA biosynthesis operon was not through effects on Und-P, we asked whether deletion of the first gene in ECA synthesis, wecA, and deletion of a gene in an intermediate step of ECA synthesis, wecE, would have to the same effects on envelope permeability in a ΔyhdP strain. Deletions of both wecA and wecE caused slight vancomycin resistance and SDS EDTA sensitivity in a yhdP+ background; however, when they were combined in the ΔyhdP deletion strain, the vancomycin and SDS EDTA resistance were both restored to the level of the ECA mutants alone (Fig. 3B). As both ΔwecA and ΔwecE mutant strains fully suppress the envelope permeability defects of a ΔyhdP strain despite having opposite effects on availability of Und-P and precursors, these data demonstrate that the suppression for the ΔyhdP strain is not due to modification of the peptidoglycan biosynthesis pathway.
Because of peptidoglycan defects and the accumulation of Und-P-linked ECA precursors, disruption of the ECA operon can also activate the Cpx, Rcs, and σE stress responses (10, 11). In fact, in Serratia marcescens, even disruption of wecA can activate the Rcs response (12). Therefore, we tested whether activation of stress responses was responsible for suppression of the ΔyhdP strain's envelope permeability by disruption of the ECA biosynthesis operon. The Cpx and Rcs stress responses are nonessential and their activity can be prevented by removal of their response regulators, CpxR and RcsB, respectively (54, 55). Disruption of cpxR has no effect on the suppression of the ΔyhdP strain's vancomycin sensitivity by ΔwecA, although synthetic SDS EDTA sensitivity in ΔwecA ΔcpxR double mutants prevents assessment of the role of Cpx on SDS EDTA sensitivity caused by yhdP deletion (Fig. 3C). Disruption of rcsB has no effect on the suppression of either the ΔyhdP strain's vancomycin or SDS EDTA sensitivity by the wecA deletion (Fig. 3D). These data demonstrate that neither the Cpx nor the Rcs stress response is necessary for the suppression of the ΔyhdP strain's phenotypes by the disruption of ECA biosynthesis. Although the σE response is essential in E. coli (56), the activation of the σE response can be monitored using reporters linked to σE-responsive promoters. One such reporter consists of the micA promoter, driving expression of green fluorescent protein (GFP) (57). Using this reporter, we found that activation of the σE response by ECA operon disruptions was not necessary for these disruptions to suppress the ΔyhdP strain's envelope permeability (Fig. 3E). These data together with the rarity of other suppressing mutations for ΔyhdP strongly suggest that YhdP is functionally connected with ECA.
The genes for YhdP and ECA occur in the same genomes.
As our data suggested that ECA and YhdP may interact and ECA is restricted to Enterobacteriaceae, we examined the phylogenetic distribution of yhdP. We used STRING-DB (39) to search for possible homologues of yhdP and to score the homology of the detected genes. The vast majority of the homologues for yhdP were found to be in Enterobacteriaceae. In fact, homologues of YhdP outside of Enterobacteriaceae are only detected in some other Gammaprotobacteria and some Betaprotobacteria; however, none of the YhdP homologues detected for YhdP outside of Enterobacteriaceae had a higher homology with E. coli K-12 YhdP than a possible homologue in Indian rice (Oryza sativa Indica) (Fig. S5A). As YhdP is part of a family of proteins, the AsmA family (58), the yhdP homologues detected outside Enterobacteriaceae possibly represent other members of the AsmA family.
To examine further the distribution of the ECA biosynthetic genes and yhdP, we used STRING-DB (39) to calculate phylogenetic co-occurrence scores based on genes with homology found across genomes. The three genes within the wec operon whose products form a complex to flip ECA to the outer leaflet of the IM (wzxE), polymerize ECA (wzyE), and control ECA chain length (wzzE) have phylogenetic co-occurrence scores with each other of 0.70 to 0.78 (Fig. S5B). The co-occurrence scores for these genes with yhdP range from 0.40 to 0.76, which are within the range of the co-occurrence scores for pairs of genes within the wec operon (0.15 to 0.78). The highest co-occurrence pair for yhdP was found with wzzE. These data demonstrate that genomes containing the machinery to make ECA also contain yhdP.
YhdP changes ECA levels.
Given that YhdP and ECA are functionally related, we investigated whether deletion of ΔyhdP causes changes to ECA abundance or chain length. There is no apparent change in the surface exposure of ECAPG or ECALPS in the absence of yhdP (Fig. S6). By immunoblotting, we detected ECALPS and ECAPG and compared the levels and chain length with and without yhdP (Fig. 4B). We observed a range of bands with the lowest molecular weight band likely indicating molecules with one repeat unit of ECA and higher molecular weight bands indicating molecules with more repeat units of ECA. Lanes 2 and 7 show a combination of ECALPS and ECAPG due to the wild-type genetic background, while lanes 4 and 9 (ΔwaaL strains) show ECAPG alone, as ECALPS cannot be produced in these strains (Fig. 4A). Given the lack of bands with ΔwecA samples where there is no ECA, all bands other than the band designated with an asterisk were taken to be ECA. Due to the use of a polyclonal antibody, the levels of ECALPS and ECAPG cannot be directly compared.
There was no apparent difference in chain length between yhdP+ and ΔyhdP strains (lanes 2 and 7); however, levels of ECALPS and ECAPG together (lanes 2 and 7) were higher in a ΔyhdP strain than in a yhdP+ strain. This is also true for ECAPG alone (lanes 4 and 9). Interestingly, this 2- to 3-fold increase in ECA levels only occurred in the presence of wzzE (Fig. 4C). The reason for the large increase in ECAPG levels between the ΔwaaL and ΔwzzE ΔwaaL strains remains an interesting question for further investigation.
Unlike the lipid-linked forms of ECA, ECACYC is not charged and cannot be detected by immunoblotting (Fig. 4A). Instead, we utilized a quantitative MALDI-TOF (matrix-assisted laser desorption ionization-time of flight) approach to detect and quantitate ECACYC in purified samples. By examining the m/z ratios of ECACYC peaks, which are present in wzzE+ strains and absent in ΔwzzE strains (Fig. 4A), we determined that the cyclization and nonstoichiometric acetylation of ECACYC were not changed in a ΔyhdP strain (Fig. S7A). Therefore, to quantitate ECACYC levels, we utilized ΔwecH strains that do not acetylate ECA and that do not affect ΔyhdP phenotypes to minimize the number of ECACYC peaks. We then grew yhdP+ strains with a nitrogen source containing 15N and ΔyhdP cells with a nitrogen source containing 14N. This shifted the m/z ratio of the ECACYC by 12, as ECACYC contains 12 nitrogen atoms, and allowed the comparison of the yhdP+ and ΔyhdP strains' ECACYC on the same spectra (Fig. S7B).
To quantitate relative ECACYC levels, we combined yhdP+ cells grown with 15N with an equal number of ΔyhdP cells grown with 14N as one sample before purification of ECACYC, allowing direct comparison of the peaks generated from each strain. This approach indicated that levels of ECACYC are decreased in the ΔyhdP strain (Fig. 4D). Over several biological replicates, we found the decrease in the ΔyhdP strain to be almost 8-fold (Fig. 4E). The phylogenetic co-occurrence of yhdP with ECA biosynthesis genes and the changes to ECA in the absence of YhdP provides further evidence that YhdP plays a role related to ECA.
YhdP prevents ECACYC from damaging the OM permeability barrier.
Given that the different forms of ECA are present in different cellular compartments and presumably play different roles, we then asked which form of ECA is responsible for the ΔyhdP strain's phenotypes. We hypothesized that one of the membrane-associated forms of ECA would be responsible for the permeability defects, as these molecules are part of the OM and the levels of these molecules are increased when YhdP is removed. We tested this hypothesis by removing specific forms of ECA and determining whether the ΔyhdP strain's envelope permeability was suppressed.
We compared wecA deletion, which removes all forms of ECA (46) and suppresses, with waaL deletion, which specifically prevents the formation of ECALPS (29), and with wzzE deletion, which prevents the formation of ECACYC but allows the formation of ECALPS and ECAPG, albeit with random chain length (28, 34). Currently, there is no way to remove ECAPG without removing the other forms of ECA. We observed full suppression of the ΔyhdP strain's envelope permeability with both the wecA and wzzE deletions; however, waaL deletion had no effect on the ΔyhdP strain's phenotypes (Fig. 5A). These data demonstrate that ECALPS does not contribute to the ΔyhdP strain's phenotypes. The suppression of the ΔyhdP strain by wzzE deletion did not rely on stress response activation (Fig. S8).
WzzE is the chain length regulator for ECA (28) and its removal causes several changes to ECA, some of which can be observed in Fig. 4B (compare lanes 2 and 3 and lanes 4 and 5): (i) the amount of ECALPS and ECAPG is increased; (ii) more short (less than 6 copies) and long (more than 7 copies) ECA chains are made; (iii) no ECACYC is produced (see Fig. S7). Given that completely removing ECA suppresses the ΔyhdP strain's phenotypes and yhdP deletion increases levels of ECALPS and ECAPG, we find it unlikely that the mechanism through which wzzE deletion suppresses the ΔyhdP strain's phenotypes is through further increasing these levels. To investigate the possibility that increasing or decreasing ECA chain length suppresses the ΔyhdP strain, we tested the ΔyhdP strain's envelope permeability and suppression at 30°C, where the modal chain length of ECA appears to be four copies; at 37°C the modal chain length of ECA is six to seven copies (Fig. 5B). Although intrinsic sensitivities to SDS EDTA and vancomycin differ between these temperatures, neither temperature suppresses the ΔyhdP strain's phenotypes, nor does the suppression of the ΔyhdP strain occur by preventing ECA synthesis change. Thus, despite the fact that yhdP deletion lowered ECACYC levels, preventing ECACYC synthesis suppressed the envelope permeability of ΔyhdP strains, demonstrating a specific, functional interaction between YhdP and ECACYC.
ECACYC maintains the OM permeability barrier.
As the presence of ECACYC leads to damage to the OM permeability barrier in the absence of YhdP, we then asked whether, in wild-type cells, ECACYC plays a broader role in maintaining the OM permeability barrier. With high-throughput studies, the specificity of effects caused by insertions in the wec operon can be unclear, as these mutations, including those in wzzE, can be polar, causing loss of all ECA species (28). Thus, we investigated changes to envelope permeability with clean wzzE deletion.
Cells with ΔwzzE showed a level of vancomycin resistance that was higher than that in wzzE+ cells and was, in fact, equal to that of ΔwecA cells (Fig. 6). The vancomycin resistance was similar to that observed with deletion of mlaA. MlaA is the first protein in the Mla pathway, which facilitates retrograde phospholipid transport and is responsible for preventing phospholipids from accumulating in the outer leaflet of the OM (59). In addition to vancomycin resistance, ΔwzzE cells also show sensitivity to deoxycholate, a detergent derived from bile salts, although less than that observed in ΔwecA cells. Deletion of waaL, which prevents formation of ECALPS, had no effect on vancomycin resistance or DOC sensitivity. As WaaL does not influence deoxycholate resistance, these data suggest that both ECAPG and ECACYC contribute to the deoxycholate phenotype, while ECACYC is responsible for vancomycin phenotype. Interestingly, combining strain ΔwzzE and mlaA deletion leads to an increase in SDS EDTA, deoxycholate, and bile salt sensitivity over that observed with either parent strain. This increase in detergent sensitivity suggests that combining these deletions causes larger changes to the OM than result from the individual mutations. Overall, these data demonstrate removal of ECACYC causes clear changes to the OM permeability barrier.
DISCUSSION
In this work, we have established that ECACYC helps to maintain the OM permeability barrier and that YhdP controls this activity of ECACYC in such a way as to prevent damage to the OM. ECACYC, not the membrane-associated form of ECA, is responsible for some of the OM permeability phenotypes caused by removal of ECA. Furthermore, in a ΔyhdP background, uncontrolled aberrant activity of ECACYC causes envelope permeability despite the fact that removing YhdP greatly lowered levels of ECACYC. This role in maintenance of the OM permeability barrier is the first phenotype described for ECACYC.
ECA is conserved throughout Enterobacteriaceae despite one of the OM forms acting as a surface-exposed common antigen that can lead to antibody production (29). Therefore, ECA must perform cellular functions that justify not only the risk of expressing a common antigen but also the potential for damage caused by ECACYC. For the surface-exposed forms of ECA, one can imagine roles relating to direct host interactions, such as receptor binding interactions, interactions with other members of Enterobacteriaceae, or roles directly influencing the penetration of toxic substances into the cell; however, it is very difficult to imagine that ECACYC, from its location in the periplasm, is responsible for interacting with the environment. Instead, ECACYC must play a role intrinsic to the cell. The changes in OM permeability that occur with removal of ECACYC demonstrate that ECACYC plays a role in maintaining the barrier function of the OM.
ECACYC, as a cyclic soluble molecule made of aminosugars, has some resemblance to cyclodextrins. Cyclodextrins are cyclic carbohydrates made of glucose monomers that have a hydrophilic exterior and a hydrophobic cavity that allows them to bind to hydrophobic guests to increase their solubility and decrease their volubility (60). In fact, some cyclodextrins can pull specific molecules, such as cholesterol, out of membranes without binding to or disrupting the membranes (61–63). These properties have led to their use in drug formulations, as food additives, in cosmetics, as air deodorizers, and in many other applications (64). It is tempting to speculate that ECACYC may have similar properties allowing it to bind to specific target molecules in the periplasm and transfer them to or from the OM. In this case, it may be that YhdP is responsible for controlling what molecules are bound or where and how the molecules are unloaded.
Despite the large size of YhdP and strong phenotypes caused by its removal (36, 38), it is not apparent that YhdP has any unique role independent of ECACYC, emphasizing the importance to the cell of controlling ECACYC activity. This also makes YhdP an important tool allowing for investigation of the effects of uncontrolled ECACYC in order to elucidate its normal function. The decrease in ECACYC in the ΔyhdP strain likely reflects a cellular mechanism to decrease the OM damage due to ECACYC in the absence of YhdP. The cell compensates for the loss of YhdP either through decreased synthesis or increased degradation of ECACYC to minimize OM damage. It is also possible that some ECACYC may leak out of ΔyhdP cells due to the OM damage; however, the methods for detecting ECACYC make this very difficult to determine. Nevertheless, even the low levels of ECACYC remaining are capable of damaging the OM barrier when its activity is uncontrolled. In the future, it will be of interest to investigate the mechanisms through which ECA levels are regulated. Nevertheless, our data suggest that, in the absence of ECACYC downregulation, the phenotypes of the ΔyhdP strain would be extremely severe.
Although the structure and topology of YhdP have not been experimentally determined, it is predicted to be an inner membrane protein with an N-terminal and possibly a C-terminal transmembrane helix, with the remainder of the protein exposed in the periplasm (37). YhdP is classified as a member of the AsmA family of proteins due to the presence of a C-terminal AsmA_2 domain and an N-terminal DUF3971 domain, which contain shared sequence motifs with those found in AsmA (58). In E. coli, there are six members of this family, AsmA, YhdP, TamB (YtfN), YhjG, YicH, and YdbH (65). Although the function of these proteins is largely unknown, mutations in asmA have been found to suppress assembly-defective mutations in OMPs (66, 67). In addition, TamB has been suggested to interact with the OMP TamA to allow secretion of autotransporters (68). Half of the DUF490 domain of TamA has been crystallized and found to adopt a “taco-shaped” β-sheet with a hydrophobic cavity (69). The remainder of the protein is thought to adopt a similar conformation, perhaps allowing amphipathic OMP segments to be transferred to TamA to avoid the aqueous periplasm. This structure is similar to that of the β-jellyroll conformation found in the LptA protein responsible for LPS transport across the periplasm (69, 70).
Although TamA and YhdP share only 25% identity, it is possible that YhdP adopts a similar conformation allowing it to bind to hydrophobic molecules. If this is the case, then YhdP may bind to hydrophobic molecules and pass them to ECACYC or unload molecules from ECACYC. We are currently investigating the specific mechanisms and pathways through which YhdP and ECACYC act, including the possibility that YhdP and ECACYC may interact physically. Nevertheless, the functional interaction between YhdP and ECACYC and the strong phenotype caused by ECACYC in the absence of YhdP represent an important aspect to envelope biology that has yet to be explored.
The difference in cellular location between ECACYC and the other forms of ECA, the ability of the cell to make three forms of ECA, and the differing antibiotic sensitivities with removal between these forms, suggests that the function of ECACYC and YhdP are likely not the same as the functions of ECAPG and ECALPS. In addition, while ECAPG has a role, direct or indirect, in excluding toxic substances, ECALPS appears to have no role in maintaining the OM permeability barrier and may instead have a role in interacting with the environment or be a by-product of the reaction that attaches O antigen to LPS. Interestingly, when investigating changes to the various forms of ECA in the presence and absence of yhdP, we observed that the modal chain length of the membrane-bound forms of ECA varied based on temperature. Knowledge on changes in ECA chain length in response to temperature has not been reported. This change in chain length may be due to specific regulation of ECA length by temperature or by a temperature-dependent change in the activity of the ECA polymerase, WzyE. However, in Yersinia enterocolitica, expression of ECA has been found to be modulated by temperature changes, with high levels of ECA at 22°C and almost undetectable levels at 37°C (71, 72). These data suggest that the functional requirements for the membrane-bound forms of ECA may depend on temperature. Furthermore, the differences in regulation of ECA expression between genera in Enterobacteriaceae suggest that the role of ECA may be adapted or modified for the lifestyles of different species. Investigation of these differences may lead to interesting insights into the biology of these species.
MATERIALS AND METHODS
Strains and growth conditions.
The strains used in this work are listed in Table S2. Cultures were grown at 37°C in LB medium unless otherwise noted. When necessary, cultures were supplemented with 20 mg/liter chloramphenicol, 25 mg/liter kanamycin, or 25 mg/liter tetracycline. To quantitate ECACYC levels, cells were grown in M63 medium without nitrogen and supplemented with 0.2% glucose, 0.2% (NH4)2SO4, 1 mM MgSO4, and 100 µg/ml thiamine. Deletion alleles originated from the Keio collection (73), unless otherwise noted, and were moved into our strains by P1vir transduction (74). Unless otherwise indicated, resistance cassettes were flipped out as has been described previously (75).
Antibiotic sensitivity assays.
For growth curves, overnight cultures were diluted 1:1,000 into 2 ml fresh LB containing the compounds indicated in a 24-well format, sealed with breathable film, and grown shaking at 37°C in a BioTek Synergy H1 plate reader. The optical density at 600 nm (OD600) was assayed every 10 min. MICs were determined as has been reported elsewhere (57). The MIC was taken to be the minimum concentration of antibiotic at which no growth was observed. For efficiency of plating (EOP) assay, 10-fold dilutions of overnight cultures were made and replicate plated onto LB plates supplemented with the indicated chemicals. Plates were incubated at 30°C (unless otherwise noted) overnight and plates were imaged.
Generation and mapping of suppressor mutations.
To generate spontaneous suppressor mutants, we plated 107 ΔyhdP strain cells on LB supplemented with 70 mg/liter vancomycin and incubated the plates overnight at 30°C. Colonies were picked and subjected to secondary screening for vancomycin and SDS EDTA resistance. The suppressor mutations were mapped as has been described elsewhere (76). We generated a Tn5 mutant library in a ΔyhdP strain as has been described elsewhere (36). Our selection and screening strategy for isolating suppressing mutations is outlined in Fig. S3A. The transposon insertion site were determined by arbitrary PCR as has been described previously (59), except that the TetA-out and TetA-seq primers were replaced with Tn5-out (5′ GGTTGTAACACTGGCAGAGC 3′) and Tn5-seq (5′ TCCGTGGCAAAGCAAAAGTT 3′).
Phylogenetic co-occurrence and homologies.
To determine whether yhdP and the genes of the wec operon tend to occur in the same genomes across organisms, we utilized the co-occurrence channel of STRING-DB (39, 77). We searched the database in multiple-protein mode for yhdP and ECA biosynthesis genes and took the phylogenetic co-occurrence scores from the generated table. The derivation of these scores from homology tables has been described elsewhere (77). To examine the level of homology for possible YhdP homologues, we used the homology scores generated via the STRING database to find whether the indicated classification of organisms was predicted to have an YhdP homology and what the highest and lowest homology scores were for the organisms included in STRING-DB within that classification. These scores were then plotted.
σE reporter assay.
To determine the level of activation of the σE system, we utilized a plasmid reporter with the promoter from micA driving expression of GFP (57) as has been reported elsewhere (78). Each of the three independent experiments was conducted in technical triplicate. The significance of the differences observed was calculated using the nonparametric Mann-Whitney test.
Quantification of ECA levels.
Membrane-associated forms of ECA were analyzed by immunoblot analysis. Cells from an overnight culture were resuspended in BugBuster protein extraction reagent (Millipore Sigma) at an equivalent OD600 of 40 and then combined with an equal volume of Laemmli sample buffer (Bio-Rad) with 4% β-mercaptoethanol. Samples were boiled 5 min and then cooled and loaded on 12% TGX gels (Bio-Rad). The samples were transferred to nitrocellulose and were probed with a 1:10,000 dilution of anti-ECA antibody. Rabbit polyclonal anti-ECA antibody was a kind gift from Renato Morona (University of Adelaide). Donkey anti-rabbit secondary antibody conjugated to horseradish peroxidase was utilized at a 1:20,000 dilution and detected using a Crescendo ECL system (Millipore Sigma). The specificity of the ECA antibody could be observed based on the lack of signal with the ΔwecA strain (Fig. 4B, lanes 1 and 6). Levels of ECA were quantitated using ImageJ. Densitometry was performed on blots with the lowest exposure at which the ECA bands for the indicated samples could be detected. Densitometry was performed on the whole lane and manually baselined. Similar results were found when each ECA band was measured individually. For each of three to five biological replicates, fold values to the yhdP+ sample were calculated. Then, the biological replicates were averaged and the standard errors of the means (SEM) were calculated. Significance was calculated using the Mann-Whitney test.
ECACYC was purified as has been described before, with minor modifications (34). Cells were grown in LB medium for determination of the ECACYC structure. For determination of ECACYC levels, cells were grown in M63 medium with either a normal or heavy (15N) nitrogen source, and cultures for comparison were combined at the beginning of purification. After ethanol precipitation, supernatants were lyophilized and subsequently resuspended with 0.1% formic acid. Acidified samples were loaded on C18 StageTips (79), washed twice with 0.1% formic acid, and eluted with 20% acetonitrile with 0.1% formic acid. Eluates were then dried in a Speedvac before reconstitution with 20% acetonitrile. Samples were analyzed by MALDI-TOF/mass spectroscopy as has been previously described (34). Spectra were obtained with a Bruker UltrafleXtreme instrument calibrated with Red phosphorous. For relative quantification, the ratio of the areas of the heavy and normal ECACYC peaks was calculated for three biological replicates. Significance was calculated using the Mann-Whitney test.
ACKNOWLEDGMENTS
We thank the current and previous members of the Silhavy laboratory for productive discussions. We thank Renato Morona (University of Adelaide) for the kind gift of anti-ECA antibody. We also thank Henry Shwe from the Princeton Department of Molecular Biology proteomics and mass spectrometry core for preparation of ECACYC samples.
This work was funded by the National Institute of General Medical Sciences grant GM118024 and fellowship F32GM116188.
Footnotes
Citation Mitchell AM, Srikumar T, Silhavy TJ. 2018. Cyclic enterobacterial common antigen maintains the outer membrane permeability barrier of Escherichia coli in a manner controlled by YhdP. mBio 9:e01321-18. https://doi.org/10.1128/mBio.01321-18.
REFERENCES
- 1.Silhavy TJ, Kahne D, Walker S. 2010. The bacterial cell envelope. Cold Spring Harb Perspect Biol 2:a000414. doi: 10.1101/cshperspect.a000414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Raetz CR, Whitfield C. 2002. Lipopolysaccharide endotoxins. Annu Rev Biochem 71:635–700. doi: 10.1146/annurev.biochem.71.110601.135414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593–656. doi: 10.1128/MMBR.67.4.593-656.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kuhn H, Meier-Dieter U, Mayer H. 1988. ECA, the enterobacterial common antigen. FEMS Microbiol Lett 54:195–222. doi: 10.1111/j.1574-6968.1988.tb02743.x. [DOI] [PubMed] [Google Scholar]
- 5.World Health Organization 2014. Antimicrobial resistance: global report on surveillance. WHO, Geneva, Switzerland. [Google Scholar]
- 6.Kunin CM. 1963. Separation, characterization, and biological significance of a common antigen in Enterobacteriaceae. J Exp Med 118:565–586. doi: 10.1084/jem.118.4.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rick PD, Hubbard GL, Barr K. 1994. Role of the rfe gene in the synthesis of the O8 antigen in Escherichia coli K-12. J Bacteriol 176:2877–2884. doi: 10.1128/jb.176.10.2877-2884.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Klena JD, Schnaitman CA. 1993. Function of the rfb gene cluster and the rfe gene in the synthesis of O antigen by Shigella dysenteriae. Mol Microbiol 9:393–402. doi: 10.1111/j.1365-2958.1993.tb01700.x. [DOI] [PubMed] [Google Scholar]
- 9.Alexander DC, Valvano MA. 1994. Role of the rfe gene in the biosynthesis of the Escherichia coli O7-specific lipopolysaccharide and other O-specific polysaccharides containing N-acetylglucosamine. J Bacteriol 176:7079–7084. doi: 10.1128/jb.176.22.7079-7084.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Danese PN, Oliver GR, Barr K, Bowman GD, Rick PD, Silhavy TJ. 1998. Accumulation of the enterobacterial common antigen lipid II biosynthetic intermediate stimulates degP transcription in Escherichia coli. J Bacteriol 180:5875–5884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Jorgenson MA, Kannan S, Laubacher ME, Young KD. 2016. Dead-end intermediates in the enterobacterial common antigen pathway induce morphological defects in Escherichia coli by competing for undecaprenyl phosphate. Mol Microbiol 100:1–14. doi: 10.1111/mmi.13284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Castelli ME, Véscovi EG. 2011. The Rcs signal transduction pathway is triggered by enterobacterial common antigen structure alterations in Serratia marcescens. J Bacteriol 193:63–74. doi: 10.1128/JB.00839-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Klein KA, Fukuto HS, Pelletier M, Romanov G, Grabenstein JP, Palmer LE, Ernst R, Bliska JB. 2012. A transposon site hybridization screen identifies galU and wecBC as important for survival of Yersinia pestis in murine macrophages. J Bacteriol 194:653–662. doi: 10.1128/JB.06237-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Phan MD, Peters KM, Sarkar S, Lukowski SW, Allsopp LP, Gomes Moriel DG, Achard MES, Totsika M, Marshall VM, Upton M, Beatson SA, Schembri MA. 2013. The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet 9:e1003834. doi: 10.1371/journal.pgen.1003834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Suezawa C, Yasuda M, Negayama K, Kameyama T, Hirauchi M, Nakai T, Okuda J. 2016. Identification of genes associated with the penetration activity of the human type of Edwardsiella tarda EdwGII through human colon epithelial cell monolayers. Microb Pathog 95:148–156. doi: 10.1016/j.micpath.2016.04.007. [DOI] [PubMed] [Google Scholar]
- 16.Bohm K, Porwollik S, Chu W, Dover JA, Gilcrease EB, Casjens SR, McClelland M, Parent KN. 2018. Genes affecting progression of bacteriophage P22 infection in Salmonella identified by transposon and single gene deletion screens. Mol Microbiol 108:288–305. doi: 10.1111/mmi.13936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Barua S, Yamashino T, Hasegawa T, Yokoyama K, Torii K, Ohta M. 2002. Involvement of surface polysaccharides in the organic acid resistance of Shiga toxin-producing Escherichia coli O157:H7. Mol Microbiol 43:629–640. doi: 10.1046/j.1365-2958.2002.02768.x. [DOI] [PubMed] [Google Scholar]
- 18.Ramos-Morales F, Prieto AI, Beuzón CR, Holden DW, Casadesús J. 2003. Role for Salmonella enterica enterobacterial common antigen in bile resistance and virulence. J Bacteriol 185:5328–5332. doi: 10.1128/JB.185.17.5328-5332.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Gilbreath JJ, Colvocoresses Dodds J, Rick PD, Soloski MJ, Merrell DS, Metcalf ES. 2012. Enterobacterial common antigen mutants of Salmonella enterica serovar Typhimurium establish a persistent infection and provide protection against subsequent lethal challenge. Infect Immun 80:441–450. doi: 10.1128/IAI.05559-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Lugowski C, Romanowska E, Kenne L, Lindberg B. 1983. Identification of a trisaccharide repeating-unit in the enterobacterial common-antigen. Carbohydr Res 118:173–181. doi: 10.1016/0008-6215(83)88045-8. [DOI] [PubMed] [Google Scholar]
- 21.Männel D, Mayer H. 1978. Isolation and chemical characterization of the enterobacterial common antigen. Eur J Biochem 86:361–370. doi: 10.1111/j.1432-1033.1978.tb12318.x. [DOI] [PubMed] [Google Scholar]
- 22.Rick PD, Mayer H, Neumeyer BA, Wolski S, Bitter-Suermann D. 1985. Biosynthesis of enterobacterial common antigen. J Bacteriol 162:494–503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Barr K, Nunes-Edwards P, Rick PD. 1989. In vitro synthesis of a lipid-linked trisaccharide involved in synthesis of enterobacterial common antigen. J Bacteriol 171:1326–1332. doi: 10.1128/jb.171.3.1326-1332.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Rick P, Silver R. 1996. Enterobacterial common antigen and capsular polysaccharides, p 104–122. In Neidhardt FC, Curtiss R III, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff WS, Riley M, Schaechter M, Umbarger HE (ed), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, DC. [Google Scholar]
- 25.Rahman A, Barr K, Rick PD. 2001. Identification of the structural gene for the TDP-Fuc4NAc:lipid II Fuc4NAc transferase involved in synthesis of enterobacterial common antigen in Escherichia coli K-12. J Bacteriol 183:6509–6516. doi: 10.1128/JB.183.22.6509-6516.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Rick PD, Barr K, Sankaran K, Kajimura J, Rush JS, Waechter CJ. 2003. Evidence that the wzxE gene of Escherichia coli K-12 encodes a protein involved in the transbilayer movement of a trisaccharide-lipid intermediate in the assembly of enterobacterial common antigen. J Biol Chem 278:16534–16542. doi: 10.1074/jbc.M301750200. [DOI] [PubMed] [Google Scholar]
- 27.Brade H. 1999. Endotoxin in health and disease. CRC Press, Boca Raton, FL. [Google Scholar]
- 28.Barr K, Klena J, Rick PD. 1999. The modality of enterobacterial common antigen polysaccharide chain lengths is regulated by o349 of the wec gene cluster of Escherichia coli K-12. J Bacteriol 181:6564–6568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Schmidt G, Mannel D, Mayer H, Whang HY, Neter E. 1976. Role of a lipopolysaccharide gene for immunogenicity of the enterobacterial common antigen. J Bacteriol 126:579–586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Kuhn HM, Neter E, Mayer H. 1983. Modification of the lipid moiety of the enterobacterial common antigen by the “Pseudomonas factor.” Infect Immun 40:696–700. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Rinno J, Golecki JR, Mayer H. 1980. Localization of enterobacterial common antigen: immunogenic and nonimmunogenic enterobacterial common antigen-containing Escherichia coli. J Bacteriol 141:814–821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Acker G, Bitter-Suermann D, Meier-Dieter U, Peters H, Mayer H. 1986. Immunocytochemical localization of enterobacterial common antigen in Escherichia coli and Yersinia enterocolitica cells. J Bacteriol 168:348–356. doi: 10.1128/jb.168.1.348-356.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Erbel PJA, Barr K, Gao N, Gerwig GJ, Rick PD, Gardner KH. 2003. Identification and biosynthesis of cyclic enterobacterial common antigen in Escherichia coli. J Bacteriol 185:1995–2004. doi: 10.1128/JB.185.6.1995-2004.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kajimura J, Rahman A, Rick PD. 2005. Assembly of cyclic enterobacterial common antigen in Escherichia coli K-12. J Bacteriol 187:6917–6927. doi: 10.1128/JB.187.20.6917-6927.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Dell A, Oates J, Lugowski C, Romanowska E, Kenne L, Lindberg B. 1984. The enterobacterial common-antigen, a cyclic polysaccharide. Carbohydr Res 133:95–104. doi: 10.1016/0008-6215(84)85186-1. [DOI] [PubMed] [Google Scholar]
- 36.Mitchell AM, Wang W, Silhavy TJ. 2017. Novel RpoS-dependent mechanisms strengthen the envelope permeability barrier during stationary phase. J Bacteriol 199:e00708-16. doi: 10.1128/JB.00708-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Krogh A, Larsson Br, von Heijne G, Sonnhammer ELL. 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes1. J Mol Biol 305:567–580. doi: 10.1006/jmbi.2000.4315. [DOI] [PubMed] [Google Scholar]
- 38.Nichols RJ, Sen S, Choo YJ, Beltrao P, Zietek M, Chaba R, Lee S, Kazmierczak KM, Lee KJ, Wong A, Shales M, Lovett S, Winkler ME, Krogan NJ, Typas A, Gross CA. 2011. Phenotypic landscape of a bacterial cell. Cell 144:143–156. doi: 10.1016/j.cell.2010.11.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, Jensen LJ, von Mering C. 2017. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 45:D362–D368. doi: 10.1093/nar/gkw937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Nikaido H, Vaara M. 1985. Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49:1–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Pootoolal J, Neu J, Wright GD. 2002. Glycopeptide antibiotic resistance. Annu Rev Pharmacol Toxicol 42:381–408. doi: 10.1146/annurev.pharmtox.42.091601.142813. [DOI] [PubMed] [Google Scholar]
- 42.Nikaido H. 2005. Restoring permeability barrier function to outer membrane. Chem Biol 12:507–509. doi: 10.1016/j.chembiol.2005.05.001. [DOI] [PubMed] [Google Scholar]
- 43.Sklar JG, Wu T, Gronenberg LS, Malinverni JC, Kahne D, Silhavy TJ. 2007. Lipoprotein SmpA is a component of the YaeT complex that assembles outer membrane proteins in Escherichia coli. Proc Natl Acad Sci U S A 104:6400–6405. doi: 10.1073/pnas.0701579104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Ricci DP, Hagan CL, Kahne D, Silhavy TJ. 2012. Activation of the Escherichia coli beta-barrel assembly machine (Bam) is required for essential components to interact properly with substrate. Proc Natl Acad Sci U S A 109:3487–3491. doi: 10.1073/pnas.1201362109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Rigel NW, Schwalm J, Ricci DP, Silhavy TJ. 2012. BamE modulates the Escherichia coli beta-barrel assembly machine component BamA. J Bacteriol 194:1002–1008. doi: 10.1128/JB.06426-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Meier-Dieter U, Barr K, Starman R, Hatch L, Rick PD. 1992. Nucleotide sequence of the Escherichia coli rfe gene involved in the synthesis of enterobacterial common antigen. Molecular cloning of the rfe-rff gene cluster. J Biol Chem 267:746–753. [PubMed] [Google Scholar]
- 47.Marolda CL, Valvano MA. 1995. Genetic analysis of the dTDP-rhamnose biosynthesis region of the Escherichia coli VW187 (O7:K1) rfb gene cluster: identification of functional homologs of rfbB and rfbA in the rff cluster and correct location of the rffE gene. J Bacteriol 177:5539–5546. doi: 10.1128/jb.177.19.5539-5546.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Grabowicz M, Andres D, Lebar MD, Malojčić G, Kahne D, Silhavy TJ. 2014. A mutant Escherichia coli that attaches peptidoglycan to lipopolysaccharide and displays cell wall on its surface. eLife 3:e05334. doi: 10.7554/eLife.05334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Tamaki S, Nakajima S, Matsuhashi M. 1977. Thermosensitive mutation in Escherichia coli simultaneously causing defects in penicillin-binding protein-1Bs and in enzyme activity for peptidoglycan synthesis in vitro. Proc Natl Acad Sci U S A 74:5472–5476. doi: 10.1073/pnas.74.12.5472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Marquardt JL, Siegele DA, Kolter R, Walsh CT. 1992. Cloning and sequencing of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferase. J Bacteriol 174:5748–5752. doi: 10.1128/jb.174.17.5748-5752.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Apfel CM, Takács B, Fountoulakis M, Stieger M, Keck W. 1999. Use of genomics to identify bacterial undecaprenyl pyrophosphate synthetase: cloning, expression, and characterization of the essential uppS gene. J Bacteriol 181:483–492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Paradis-Bleau C, Kritikos G, Orlova K, Typas A, Bernhardt TG. 2014. A genome-wide screen for bacterial envelope biogenesis mutants identifies a novel factor involved in cell wall precursor metabolism. PLoS Genet 10:e1004056. doi: 10.1371/journal.pgen.1004056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.El Ghachi M, Bouhss A, Blanot D, Mengin-Lecreulx D. 2004. The bacA gene of Escherichia coli encodes an undecaprenyl pyrophosphate phosphatase activity. J Biol Chem 279:30106–30113. doi: 10.1074/jbc.M401701200. [DOI] [PubMed] [Google Scholar]
- 54.Dong J, Iuchi S, Kwan HS, Lu Z, Lin EC. 1993. The deduced amino-acid sequence of the cloned cpxR gene suggests the protein is the cognate regulator for the membrane sensor, CpxA, in a two-component signal transduction system of Escherichia coli. Gene 136:227–230. doi: 10.1016/0378-1119(93)90469-J. [DOI] [PubMed] [Google Scholar]
- 55.Gottesman S, Trisler P, Torres-Cabassa A. 1985. Regulation of capsular polysaccharide synthesis in Escherichia coli K-12: characterization of three regulatory genes. J Bacteriol 162:1111–1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.De Las Peñas A, Connolly L, Gross CA. 1997. σE is an essential sigma factor in Escherichia coli. J Bacteriol 179:6862–6864. doi: 10.1128/jb.179.21.6862-6864.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Konovalova A, Grabowicz M, Balibar CJ, Malinverni JC, Painter RE, Riley D, Mann PA, Wang H, Garlisi CG, Sherborne B, Rigel NW, Ricci DP, Black TA, Roemer T, Silhavy TJ, Walker SS. 2018. Inhibitor of intramembrane protease RseP blocks the σE response causing lethal accumulation of unfolded outer membrane proteins. Proc Natl Acad Sci U S A doi: 10.1073/pnas.1806107115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Finn RD, Bateman A, Clements J, Coggill P, Eberhardt RY, Eddy SR, Heger A, Hetherington K, Holm L, Mistry J, Sonnhammer ELL, Tate J, Punta M. 2014. Pfam: the protein families database. Nucleic Acids Res 42:D222–D230. doi: 10.1093/nar/gkt1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Malinverni JC, Silhavy TJ. 2009. An ABC transport system that maintains lipid asymmetry in the Gram-negative outer membrane. Proc Natl Acad Sci U S A 106:8009–8014. doi: 10.1073/pnas.0903229106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Kfoury M, Landy D, Fourmentin S. 2018. Characterization of cyclodextrin/volatile inclusion complexes: a review. Molecules 23:1204. doi: 10.3390/molecules23051204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Ohtani Y, Irie T, Uekama K, Fukunaga K, Pitha J. 1989. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur J Biochem 186:17–22. doi: 10.1111/j.1432-1033.1989.tb15171.x. [DOI] [PubMed] [Google Scholar]
- 62.Klein U, Gimpl G, Fahrenholz F. 1995. Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 34:13784–13793. doi: 10.1021/bi00042a009. [DOI] [PubMed] [Google Scholar]
- 63.Yancey PG, Rodrigueza WV, Kilsdonk EP, Stoudt GW, Johnson WJ, Phillips MC, Rothblat GH. 1996. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J Biol Chem 271:16026–16034. doi: 10.1074/jbc.271.27.16026. [DOI] [PubMed] [Google Scholar]
- 64.Crini G. 2014. Review. A history of cyclodextrins. Chem Rev 114:10940–10975. [DOI] [PubMed] [Google Scholar]
- 65.Heinz E, Selkrig J, Belousoff MJ, Lithgow T. 2015. Evolution of the translocation and assembly module (TAM). Genome Biol Evol 7:1628–1643. doi: 10.1093/gbe/evv097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Deng M, Misra R. 1996. Examination of AsmA and its effect on the assembly of Escherichia coli outer membrane proteins. Mol Microbiol 21:605–612. doi: 10.1111/j.1365-2958.1996.tb02568.x. [DOI] [PubMed] [Google Scholar]
- 67.Misra R, Miao Y. 1995. Molecular analysis of asmA, a locus identified as the suppressor of OmpF assembly mutants of Escherichia coli K-12. Mol Microbiol 16:779–788. doi: 10.1111/j.1365-2958.1995.tb02439.x. [DOI] [PubMed] [Google Scholar]
- 68.Selkrig J, Mosbahi K, Webb CT, Belousoff MJ, Perry AJ, Wells TJ, Morris F, Leyton DL, Totsika M, Phan M-D, Celik N, Kelly M, Oates C, Hartland EL, Robins-Browne RM, Ramarathinam SH, Purcell AW, Schembri MA, Strugnell RA, Henderson IR, Walker D, Lithgow T. 2012. Discovery of an archetypal protein transport system in bacterial outer membranes. Nat Struct Mol Biol 19:506–510. doi: 10.1038/nsmb.2261. [DOI] [PubMed] [Google Scholar]
- 69.Josts I, Stubenrauch CJ, Vadlamani G, Mosbahi K, Walker D, Lithgow T, Grinter R. 2017. The structure of a conserved domain of TamB reveals a hydrophobic β taco fold. Structure 25:1898–1906.e5. doi: 10.1016/j.str.2017.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Bollati M, Villa R, Gourlay LJ, Benedet M, Dehò G, Polissi A, Barbiroli A, Martorana AM, Sperandeo P, Bolognesi M, Nardini M. 2015. Crystal structure of LptH, the periplasmic component of the lipopolysaccharide transport machinery from Pseudomonas aeruginosa. FEBS J 282:1980–1997. doi: 10.1111/febs.13254. [DOI] [PubMed] [Google Scholar]
- 71.Muszyński A, Rabsztyn K, Knapska K, Duda KA, Duda-Grychtoł K, Kasperkiewicz K, Radziejewska-Lebrecht J, Holst O, Skurnik M. 2013. Enterobacterial common antigen and O-specific polysaccharide coexist in the lipopolysaccharide of Yersinia enterocolitica serotype O:3. Microbiology 159:1782–1793. doi: 10.1099/mic.0.066662-0. [DOI] [PubMed] [Google Scholar]
- 72.Rabsztyn K, Kasperkiewicz K, Duda KA, Li CM, Lukasik M, Radziejewska-Lebrecht J, Skurnik M. 2011. Characterization of anti-ECA antibodies in rabbit antiserum against rough Yersinia enterocolitica O:3. Biochemistry 76:832–839. doi: 10.1134/S0006297911070145. [DOI] [PubMed] [Google Scholar]
- 73.Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2:2006.0008. doi: 10.1038/msb4100050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Silhavy TJ, Berman ML, Enquist LW. 1984. Experiments with gene fusions. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. [Google Scholar]
- 75.Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640–6645. doi: 10.1073/pnas.120163297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Button JE, Silhavy TJ, Ruiz N. 2007. A suppressor of cell death caused by the loss of σE downregulates extracytoplasmic stress responses and outer membrane vesicle production in Escherichia coli. J Bacteriol 189:1523–1530. doi: 10.1128/JB.01534-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Franceschini A, Lin J, von Mering C, Jensen LJ. 2016. SVD-phy: improved prediction of protein functional associations through singular value decomposition of phylogenetic profiles. Bioinformatics 32:1085–1087. doi: 10.1093/bioinformatics/btv696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Konovalova A, Schwalm JA, Silhavy TJ. 2016. A suppressor mutation that creates a faster and more robust σE envelope stress response. J Bacteriol 198:2345–2351. doi: 10.1128/JB.00340-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Rappsilber J, Mann M, Ishihama Y. 2007. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2:1896–1906. doi: 10.1038/nprot.2007.261. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.